92 related articles for article (PubMed ID: 8074468)
1. Augmentation of interleukin-6 (IL-6) expression in squamous carcinoma cells and normal human keratinocytes treated with recombinant anti-neoplastic protein (ACP).
McKenzie RC; Venner TJ; Sauder DN; Farkas-Himsley H
Anticancer Res; 1994; 14(3A):1165-8. PubMed ID: 8074468
[TBL] [Abstract][Full Text] [Related]
2. Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines.
Chen Z; Colon I; Ortiz N; Callister M; Dong G; Pegram MY; Arosarena O; Strome S; Nicholson JC; Van Waes C
Cancer Res; 1998 Aug; 58(16):3668-76. PubMed ID: 9721877
[TBL] [Abstract][Full Text] [Related]
3. The erbstatin analogue methyl 2,5-dihydroxycinnamate cross-links proteins and is cytotoxic to normal and neoplastic epithelial cells by a mechanism independent of tyrosine kinase inhibition.
Stanwell C; Burke TR; Yuspa SH
Cancer Res; 1995 Nov; 55(21):4950-6. PubMed ID: 7585535
[TBL] [Abstract][Full Text] [Related]
4. Induction of TNF-alpha, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells.
Niiya M; Niiya K; Kiguchi T; Shibakura M; Asaumi N; Shinagawa K; Ishimaru F; Kiura K; Ikeda K; Ueoka H; Tanimoto M
Cancer Chemother Pharmacol; 2003 Nov; 52(5):391-8. PubMed ID: 12908082
[TBL] [Abstract][Full Text] [Related]
5. The differential expression of proinflammatory cytokines IL-6, IL-8 and TNF-alpha in renal cell carcinoma.
König B; Steinbach F; Janocha B; Drynda A; Stumm M; Philipp C; Allhoff EP; König W
Anticancer Res; 1999; 19(2C):1519-24. PubMed ID: 10365136
[TBL] [Abstract][Full Text] [Related]
6. Direct influences of pro-inflammatory cytokines (IL-1beta, TNF-alpha, IL-6) on the proliferation and cell-surface antigen expression of cancer cells.
Kuninaka S; Yano T; Yokoyama H; Fukuyama Y; Terazaki Y; Uehara T; Kanematsu T; Asoh H; Ichinose Y
Cytokine; 2000 Jan; 12(1):8-11. PubMed ID: 10623436
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
8. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
9. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes.
Dallos A; Kiss M; Polyánka H; Dobozy A; Kemény L; Husz S
Neuropeptides; 2006 Aug; 40(4):251-63. PubMed ID: 16904178
[TBL] [Abstract][Full Text] [Related]
10. Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism.
Loukinova E; Dong G; Enamorado-Ayalya I; Thomas GR; Chen Z; Schreiber H; Van Waes C
Oncogene; 2000 Jul; 19(31):3477-86. PubMed ID: 10918606
[TBL] [Abstract][Full Text] [Related]
11. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
12. IFN-beta 2, B cell differentiation factor 2, or hybridoma growth factor (IL-6) is expressed and released by human epidermal cells and epidermoid carcinoma cell lines.
Kirnbauer R; Köck A; Schwarz T; Urbanski A; Krutmann J; Borth W; Damm D; Shipley G; Ansel JC; Luger TA
J Immunol; 1989 Mar; 142(6):1922-8. PubMed ID: 2784142
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo.
McKenzie RC; Oran A; Dinarello CA; Sauder DN
Anticancer Res; 1996; 16(1):437-41. PubMed ID: 8615650
[TBL] [Abstract][Full Text] [Related]
14. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro SPRR1 gene expression in normal and malignant keratinocytes.
Yaar M; Eller MS; Bhawan J; Harkness DD; DiBenedetto PJ; Gilchrest BA
Exp Cell Res; 1995 Apr; 217(2):217-26. PubMed ID: 7698221
[TBL] [Abstract][Full Text] [Related]
16. Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline.
Jeng JH; Wang YJ; Chiang BL; Lee PH; Chan CP; Ho YS; Wang TM; Lee JJ; Hahn LJ; Chang MC
Carcinogenesis; 2003 Aug; 24(8):1301-15. PubMed ID: 12807728
[TBL] [Abstract][Full Text] [Related]
17. Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes.
Stoll S; Müller G; Kurimoto M; Saloga J; Tanimoto T; Yamauchi H; Okamura H; Knop J; Enk AH
J Immunol; 1997 Jul; 159(1):298-302. PubMed ID: 9200466
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of interleukin-1 receptor antagonist in different stages of mouse skin carcinogenesis.
La E; Muga SJ; Locniskar MF; Fischer SM
Mol Carcinog; 1999 Apr; 24(4):276-86. PubMed ID: 10326864
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta.
Lee SC; Liu W; Dickson DW; Brosnan CF; Berman JW
J Immunol; 1993 Apr; 150(7):2659-67. PubMed ID: 8454848
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the production of a parathyroid hormone-like protein in human squamous carcinoma cell lines by interaction with fibroblasts.
Hoekman K; Löwik CW; vd Ruit M; Kempenaar J; Bijvoet OL; Ponec M
Cancer Res; 1990 Jun; 50(12):3589-94. PubMed ID: 2160322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
